Fulcrum Metals, a holding company of a mineral exploration group with base, precious and energy metal projects in Canada, intends to join AIM. On Admission, the Group's projects will comprise six gold and base metal projects in Ontario, Canada. The Group's projects are pre-discovery with large, diversified land packages that have either substantial historical samples or prospective geology and are located nearby mineral rich deposits or producing mines. Expected mid-February 2023
DeepVerge 1.9p £14.4m (DVRG.L)
The environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins, announces the appointment of Andrew Waters FCA as Chief Financial Officer and as a Director of the Company. Andrew brings experience as a CFO of both public and private companies in the healthcare and life sciences field, including most recently at AIM quoted Venture Life Group plc. A further independent Non-Executive Director will be appointed as soon as practicable.
e-Therapeutics 16.85p £98.1m (ETX.L)
The company integrating computational power and biological data to discover life-transforming RNAi medicines, announces the filing of four new patent applications to protect innovation around novel gene targets, associated disease relevant biology as well as proprietary siRNA (short interfering RNA) stabilisation chemistries. The new patent applications build on an active period of IP generation, where a series of patent applications were filled to protect 13 inventions.
Feedback 122.5p £16.3m (FDBK.L)
The specialist clinical communication company, announces its unaudited results for the six months to 30 November 2022. Revenue increased 222% to £576k (H1 2022: £179k), while sales increased to £612k (H1 2022: £246k). Adjusted EBITDA loss increased to £1,197k (H1 2022: £1,007k) as a result of expanding and scaling the Bleepa-CareLocker platform. During the period FDBK was awarded £450k contract for a 12-month pilot extension of the Sussex Integrated Care Systems Community Diagnostic Centre development programme. Cash as at 30 November 2022 of £9,228k ( 31 May 2022: £10,306k). Looking to Q3-Q4 of this financial year, the Company's focus will be predominantly be on the NHS and pursuing opportunities in the emerging CDC space, where FDBK is seeing growing amount of government investment and substantial clinical need for our technologies.
Great Western Mining 0.086p £3.9m (GWMO.L)
An exploration company focused on gold, silver and copper targets in Nevada provides an operations update. Western Milling LLC: In January, the Nevada Department of Environmental Protection (NDEP) requested changes to be the plan for Western Milling LLC, (a production joint venture, 50% owned by the Company). A modified plan has been submitted for formal approval. Surface work started last week in preparation for laying concrete. OMCO Mine: A track-mounted reverse circulation drill rig has been secured and is currently being mobilised to the Olympic Gold site for shallow drilling at the OMCO Mine prospect. Drilling in 2022 intercepted the OMCO Mine vein for the first time and an extension to the OMCO Mine is now believed to have been established.
IXICO 25.5p £12.3m (IXI.L)
The precision analytics company delivering insights in neuroscience, provides a trading update. IXICO reconfirms its revenue expectations of £7m for the year to 30 September 2023. The Company now expects to achieve double digit revenue growth in the year to 30 September 2024. IXICO has diversified its orderbook and the Board expects to see revenue growth in 2024 as it continues to build upon the contract and client wins. The return to revenue growth is an important step on the path back to profitability.
Northcoders Group 305p £23.5m (CODE.L)
An independent provider of training programmes for software coding, announces that it has entered into a conditional agreement to acquire Tech Returners Limited, a leading UK technology re-training business for senior-level personnel for a total consideration of £1.576m, to be satisfied in cash and shares. The initial consideration of £1.326m will be satisfied on completion by payment of £326k cash and the issue of 322,580 new ordinary shares of £0.01 each in the capital of the Company. Deferred consideration of £0.25m is payable 12 months post Completion in cash. For the year ended 30 November 2021 Tech Returners reported a profit before tax of £68k on revenues of £565k and had net assets of approximately £7k. For the equivalent period to 30 November 2022 management accounts indicated revenues of over £800k and a breakeven position.
REACT Group 1.18p £12.4m (REAT.L)
The specialist cleaning, hygiene, and decontamination company, announces its final results for the year ended 30 September 2022. Revenue increased by 78% at £13.70m (2021: £7.70m), including a contribution of c. £1.6m from LaddersFree post acquisition. Gross profit increased 37% to £3.26m (2021: £2.37m) and adjusted EBITDA grew 20% to £953k (2021: £795k). In May 2022, REACT acquired LaddersFree Ltd, an established nationwide commercial window, gutter and cladding cleaning business, for a total consideration of up to £8.5m on a debt-free and cash-free basis. REACT intends to continue to build through organic growth and via strategic acquisitions if the right opportunity presents itself.
Tekcapital 21.5p £32.4m (TEK.L)
The UK intellectual property investment group notes that Innovative Eyewear, Inc. (NASDAQ: LUCY; LUCYW), the developer and retailer of smart eyewear under the Lucyd®, Nautica® and Eddie Bauer® brands, has announced the launch of Lucyd Lyte 2.0. Lucyd Lyte 2.0 is a major upgrade to its flagship Lucyd Lyte audio eyewear platform and brings several advances to the company's core product. Tekcapital currently owns 5,189,086 shares (approximately 71%) of Innovative Eyewear, Inc.
Victorian Plumbing Group 91.5p £297.6m (VIC.L)
The online specialist bathroom retailer, announces that Daniel (Dan) Barton, currently the Group's Director of Finance, has been appointed as the Group's Chief Financial Officer following the resignation of Paul Meehan. Dan will be appointed to the Board on 1 April 2023. Paul will remain with the business until 30 June 2023 to ensure an orderly handover. Dan joined Victorian Plumbing in August 2022 from DWF Group plc, where he was Deputy CFO for three years. Prior to this, Dan was Deputy CFO and Company Secretary at Wilmington Group plc, having previously qualified as a Chartered Accountant at PwC LLP.
Zinc Media Group 92.5p £20.2m (ZIN.L)
The television, brand and audio production group, provides a trading update. Revenue and adjusted EBITDA for FY22 are expected to be ahead of current market expectations, with the Group profitable (at EBITDA level) during the second half of the year. The strong Q4 performance boosted by The Edge (film producer), which had its best trading year ever. The outlook for FY23 remains positive. £15m revenue has been booked and anticipated to be delivered in FY23, and £12m of highly advanced revenue is in the pipeline for delivery in FY23.
Disclaimer
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
